| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |